Rocket


News + Filings
Transactions
Holdings


All
13F
13D/G
Other

Nestle Health Science US Holdings, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
07/22/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/14/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
09/09/2020 SC 13G/A Nestle Health Science US Holdings, Inc. reports a 11.8% stake in Axcella Health Inc.
08/19/2020 SC 13D/A Nestle Health Science US Holdings, Inc. reports a 8.8% stake in Seres Therapeutics, Inc.
05/21/2020 4 Nestle Health Science US Holdings, Inc. (10% Owner) has filed a Form 4 on Axcella Health Inc.
Txns: Bought 1,936,842 shares @ $4.75, valued at $9.2M
05/21/2020 SC 13G Nestle Health Science US Holdings, Inc. reports a 12% stake in Axcella Health Inc.
04/24/2020 3 Nestle Health Science US Holdings, Inc. (10% Owner) has filed a Form 3 on Aimmune Therapeutics, Inc.
04/24/2020 4 Nestle Health Science US Holdings, Inc. (10% Owner) has filed a Form 4 on Aimmune Therapeutics, Inc.
Txns: Bought 937,500 shares @ $32, valued at $30M
Bought 3,237,529 shares @ $30.27, valued at $98M
04/24/2020 SC 13D/A Nestle Health Science US Holdings, Inc. reports a 19.6% stake in Aimmune Therapeutics, Inc.
02/14/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
02/13/2020 SC 13G Nestle Health Science US Holdings, Inc. reports a 10.2% stake in Axcella Health Inc.
02/11/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/03/2018 SC 13D/A Nestle Health Science US Holdings, Inc. reports a 18.9% stake in Aimmune Therapeutics, Inc.
03/02/2018 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
11/28/2016 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
11/23/2016 3 Nestle Health Science US Holdings, Inc. (10% Owner) has filed a Form 3 on Aimmune Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy